Gonadorelin

FDA-approved context Hormonal Health 3 sources

Gonadorelin is a synthetic version of gonadotropin-releasing hormone (GnRH). It stimulates the anterior pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulate the gonads to produce testosterone and sperm in males, and estrogen and eggs in females.

01Dosing reference

Amount

100-200 mcg per dose

Frequency

Multiple times daily (e.g., 2-4x/day) or via pulsatile pump to mimic natural release

Cycle

Varies based on clinical or research goals; often used for 4-8 weeks

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

GnRH Receptor Binding

Gonadorelin binds to GnRH receptors on gonadotroph cells in the anterior pituitary gland.

Gonadotropin Release

This binding triggers the pulsatile release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) into the bloodstream.

Gonadal Stimulation

LH and FSH travel to the testes or ovaries, stimulating the production of sex hormones (like testosterone) and supporting gametogenesis.

03Human evidence

Effective in evaluating the functional capacity and response of the gonadotropes of the anterior pituitary.

Used clinically as a diagnostic agent for suspected gonadotropin deficiency.

Pulsatile administration can induce ovulation in women with hypothalamic amenorrhea.

Clinical trials demonstrated efficacy when administered via a specialized pump to mimic natural pulsatile GnRH release.

04Preclinical evidence

Demonstrated the necessity of pulsatile vs. continuous administration for sustained gonadotropin release.

Animal models showed that continuous GnRH exposure leads to receptor downregulation and suppression of LH/FSH.

Stimulates testosterone production in animal models of hypogonadism.

Studies in rodents confirmed the restoration of gonadal function following GnRH analog administration.

05What is known vs. unknown

Reasonably established

Identical in structure to endogenous human gonadotropin-releasing hormone (GnRH).
Must be administered in a pulsatile manner to stimulate LH and FSH; continuous administration suppresses them.
Used clinically for diagnostic testing of the hypothalamic-pituitary-gonadal axis.
Often researched as an alternative to hCG for maintaining testicular function and testosterone production.

Unknowns & limits

The optimal dosing frequency for off-label use in men to maintain natural testosterone production without causing receptor downregulation is still debated.
Long-term safety and efficacy of frequent subcutaneous injections compared to natural pulsatile release remain partially unclear outside of clinical pump use.

06Safety & regulatory context

Regulatory statusGonadorelin is FDA-approved for diagnostic use (e.g., Factrel) to assess pituitary function, and historically for therapeutic use via pulsatile pump (e.g., Lutrepulse) for infertility. Common side effects include injection site reactions, headache, flushing, and nausea. Continuous or overly frequent high-dose administration can lead to paradoxical suppression of the hypothalamic-pituitary-gonadal axis (chemical castration effect). It is available by prescription and should be used under medical supervision.

07Compared with hCG (Human Chorionic Gonadotropin)

Gonadorelin vs. hCG (Human Chorionic Gonadotropin)

Key difference

Gonadorelin stimulates the pituitary to release LH and FSH, whereas hCG acts directly on the testes by mimicking LH.

When researchers discuss each

hCG is often discussed for direct testicular stimulation, while Gonadorelin is discussed when the goal is to stimulate the entire hypothalamic-pituitary-gonadal axis.

08Glossary

GnRH

Gonadotropin-releasing hormone, a hormone produced in the hypothalamus that triggers the pituitary gland to release LH and FSH.

Luteinizing Hormone (LH)

A hormone that stimulates the Leydig cells in the testes to produce testosterone.

Pulsatile Release

The release of a hormone in short bursts or pulses, which is crucial for the proper function of GnRH.

Downregulation

A decrease in the number or sensitivity of receptors in response to continuous exposure to a hormone or drug.

09Knowledge check

Q1What happens if Gonadorelin is administered continuously rather than in a pulsatile manner?

Q2How does Gonadorelin differ from hCG in its mechanism of action?

Q3Which statement best reflects a documented limitation in the dossier about long-term off-label use of Gonadorelin injections to replicate natural pulsatile release in men?

Q4In research contexts, when investigators discuss using Gonadorelin rather than hCG, which research goal is Gonadorelin most often associated with according to the dossier?

Q5Which statement most accurately summarizes the dossier’s safety and regulatory information for Gonadorelin?

10Sources

More in Hormonal Health

See all

Kisspeptin-10

Hormonal Health

Human clinical

Kisspeptin-10 is a potent neuropeptide that acts as an upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Research shows it stimulates the release of gonadotropin-releasing hormone (GnRH), subsequently increasing luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels. It is heavily studied for its potential in treating infertility, hypogonadism, and reproductive disorders.

100-300 mcg per dose

hCG (Human Chorionic Gonadotropin)

Hormonal Health

FDA-approved context

hCG is a hormone naturally produced during pregnancy that mimics luteinizing hormone (LH) in the body. In research and clinical settings, it is widely used to stimulate testosterone production, preserve fertility, and treat hypogonadism in men, as well as to induce ovulation in women.

250-500 IU

HMG (Human Menopausal Gonadotropin)

Hormonal Health

FDA-approved context

Human Menopausal Gonadotropin (HMG) is a medication containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH), typically extracted from the urine of postmenopausal women. It is widely used in reproductive medicine to stimulate ovulation in women and spermatogenesis in men, often as part of assisted reproductive technologies (ART) or hypogonadism treatments.

75-150 IU per injection

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.